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A B S T R A C T
Magnetization transfer ratio (MTR) is a magnetic resonance imaging (MRI) method which may detect
demyelination not detected by conventional MRI in the central nervous system of patients with multi-
ple sclerosis (MS). A decrease in MTR value has previously been shown to correlate to myelin loss in the
mouse cuprizone model for demyelination. In this study, we investigated the sensitivity of MTR for de-
myelination in the myelin oligodendrocyte (MOG) 1–125 induced experimental autoimmune
encephalomyelitis (EAE) mouse model. A total of 24 female c57Bl/6 mice were randomized to a control
group (N = 6) or EAE (N = 18). MTR images were obtained at a preclinical 7 Tesla Bruker MR-scanner before
EAE induction (baseline), 17–19 days (midpoint) and 31–32 days (endpoint) after EAE induction. Mean
MTR values were calculated in ﬁve regions of the brain and compared to weight, EAE severity score and
myelin content assessed by immunostaining for proteolipid protein and luxol fast blue, lymphocyte and
monocyte inﬁltration and iron deposition. Contrary to what was expected, MTR values in the EAE mice
were higher than in the control mice at the midpoint and endpoint. No signiﬁcant difference in myelin
content was found according to histo- or immunohistochemistry. Changes in MTR values did not corre-
late to myelin content, iron content, lymphocyte or monocyte inﬁltration, weight or EAE severity scores.
This suggest that MTR measures of brain tissue can give signiﬁcant differences between control mice and
EAE mice not caused by demyelination, inﬂammation or iron deposition, and may not be useful surro-
gate markers for demyelination in the MOG1-125 mouse model.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Multiple sclerosis (MS) is a chronic disease of the central nervous
system (CNS), characterized by inﬂammation, demyelination and
axonal loss. Conventional magnetic resonance imaging (MRI) is
crucial in the diagnostic workup of MS, showing hyperintense lesions
on T2 weightedMRI. However, conventional MRI techniques are less
sensitive to gray matter lesions and axonal loss, both representing
pathophysiological mechanisms in MS which contribute signiﬁ-
cantly to disability progression of the disease. In the absence of
reliable MRI markers of disability and progression in MS patients,
magnetization transfer ratio (MTR) has been introduced as a semi-
quantitative method that may be sensitive to change in myelin
content in the CNS (Grossman, 1994). The MTR image is gener-
ated from the relative difference between two MR images (Dousset
et al., 1992), differing only in the application of a pre-applied off-
resonance saturation pulse that decreases signal intensity
proportional to the density of macromolecules. Myelin is a lipid
bilayer membrane abundant in the CNS, with a high macromol-
ecule density susceptible to the offset MT-saturation pulse. MTR has
been shown to decrease both in and in proximity of white matter
MS lesions (Dousset et al., 1998; Filippi et al., 1995, 1998), and has
detected gray matter changes in the MS brain, thus showing sen-
sitivity to both demyelination and inﬂammation (Agosta et al., 2006;
Vavasour et al., 2011). A 9.4 T post mortem study of formalin ﬁxed
MS brains showed a correlation between MTR and myelin content
(Schmierer et al., 2010). MTR has been shown to correlate to both
axonal density and myelin content from histopathological analy-
ses of post-mortem tissue from brain- and spinal cord tissue of MS
patients (Mottershead et al., 2003; Schmierer et al., 2004, 2007). In
vivo detection of diffuse white matter abnormality is associated with
decreased MTR, thought to be due to a decrease in myelin content
(Laule et al., 2011). Studies in an experimental model of toxic de-
myelination with little or no perivascular inﬂammation, the
cuprizone (CPZ) model, have found correlation between myelin
content and MTR value (Boretius et al., 2012; Fjær et al., 2013;
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Merkler et al., 2005; Zaaraoui et al., 2008). The CPZmodel is, however,
not a comprehensive model of MS pathophysiology, as it is char-
acterized by demyelination in the absence of lymphocyte activation.
Complementary to this is the experimental autoimmune enceph-
alomyelitis (EAE), a model of CD8+ T lymphocyte mediated
inﬂammation followed by demyelination, axonal degeneration and
neuronal loss (Kuerten et al., 2007). The main CNS predilection site
of EAE-induced inﬂammation is the spinal cord, and in the MOG-
induced EAE there are some reports of lesions in the brain and
cerebellum (Day, 2005). Accordingly, one study has shown a diffuse
neurodegeneration of the brain and cerebellums of MOG-EAE mice
(Mackenzie-Graham et al., 2011). In a study of MTR in brains of mar-
mosets with EAE, MTR values decreased in lesions, but not in the
cortex and normal appearing white matter (Blezer et al., 2007). In
the EAE model in guinea pigs, a decrease in MTR values was shown
both in the spinal cord and normal appearing white matter, but MTR
did not correlate to myelin water in the brain (Gareau et al., 2000),
and also showed correlation to axonal density and inﬂammation
as well as to myelin in the spinal cord (Cook et al., 2004). MTR values
has been shown to be lower in EAE induced rats compared to con-
trols (Rausch et al., 2003), and rats in the acute phase has lower MTR
values than those in a remitting phase (Berger et al., 2006). However,
MTR values have been reported to decrease before demyelination,
indicating that inﬂammatory processes also inﬂuence the MT effect
(Serres et al., 2009, 2013). It has also been shown, by a quantita-
tive magnetization transfer MRI model, that the changes in bound
proton pool fraction (f*) was more pronounced than the changes
in MTR in EAE induced rats (Rausch et al., 2009). A combined EAE-
CPZ mouse model showed a stronger decrease in MTR than mouse
only affected by CPZ, even though both groups showed similar
amount of demyelination. The stronger decrease is thought to be
due to axonal swelling, cellular inﬁltration and edema (Boretius et al.,
2012). In mice with EAE induced by proteolipid protein, a de-
crease in MTRwas seen in brainstem, cerebellum and frontal cortex,
but not olfactory bulb (Mueggler et al., 2012). In a study of the effect
of glatiramer acetate (GA) on EAE mice, the untreated EAE mice are
shown to have lower MTR values than the GA treated (Aharoni et al.,
2013). MTR is often considered to be mainly a marker of myelin
change, but others argue that MTR is more closely related to
neurodegenerative changes than to demyelination (Serres et al.,
2009). In spite of previous efforts to study the pathophysiological
correlations of changes in the MTR, questions remain with respect
to the sensitivity of MTR in gray matter, and whether gray matter
MTR is affected by diffuse neurodegeneration. The purpose of the
present study was to examine whether MTR is a sensitive method
for detecting demyelination in different brain regions in EAE mice,
and to investigate how MTR values correlated to clinical disease
activity.
2. Methods
2.1. Mice
A total of 24 female c57Bl/6 mice (Tacomic, Tornbjerg, Denmark)
were acquired at 7 weeks of age with a mean weight of 22.7 ± SD
0.85g.During the acclimatization and experimental period, theywere
housed, 6 per cage, in Macrolon IVC-II cages (Scanbur, Karlslunde,
Denmark) in standard laboratory conditions: light/dark cycles of
12/12h, cage temperature of 22.7 ± 1 °C, relative humidity of 52.9 ± 5%
and 75 air changes per hour. They had ad libitum access to normal
mouse chow (‘Rat and mouse No. I’ maintenance diet from Scanbur,
Special Diet Services, Karlslunde, Denmark) and tap water during
the acclimatization period of one week. Cage maintenance was per-
formed once weekly by the same individuals throughout the study
period. The experiment was conducted in accordance with the Fed-
eration of European Laboratory Animal Science Associations (FELASA)
recommendations, and the protocol was approved by the Norwe-
gian Animal Research Authority.
2.2. EAE induction
EAE was induced at post-immunization (p.i.) day 0 in 18 mice
by s.c. injection of 25 μg of recombinant human myelin oligoden-
drocyte glycoprotein (MOG) (Hooke Labs, Lawrence, MA, USA)
emulsiﬁed in Freund’s complete adjuvant containing 1mg/ml of My-
cobacterium tuberculosis H37Ra (Sigma-Aldrich, St Louis, MO, USA).
In addition, 200 ng of pertussis toxin (Sigma-Aldrich, St Louis, MO,
USA) was administered intraperitoneally at p.i days 0 and 2.
2.3. Weight and clinical scoring
The mice were weighted twice weekly. Clinical scoring was as-
sessed daily for signs of disease activity according to the following
guidelines: grade 0, healthy; grade 1, tail weakness; grade 2, tail pa-
ralysis; grade 3, signs of hindlimb paresis; grade 4, evident hindlimb
paresis; grade 5, marked hindlimb paralysis; grade 6, hindlimb pa-
ralysis; grade 7, tetraparalysis; grade 8, death due to EAE.
2.4. MRI protocol
The MRI experiments were performed on a 7 Tesla horizontal
bore magnet (Pharmascan 70/16, Bruker BioSpin, Bruker Corpora-
tion, Germany) using a 23 mm ID mouse-head linear volume
resonator. The mice were split into 4 groups. Three EAE exposed
groups, EAE1, EAE2 and EAE3 (Ns = 6); and one control group, CTRL
(N = 6). The mice were scanned at baseline (CTRL, EAE1, EAE2 and
EAE3), before EAE induction; at themidpoint (CTRL, EAE2 and EAE3),
17–19 days after EAE induction; and at the endpoint (CTRL, EAE1
and EAE3), 31–32 days after EAE induction. Immediately after each
mouse’s last scan, theywere sacriﬁced for histopathology (Table 1).
Table 1
Study setup.
Baseline EAE induction Midpoint Endpoint
Day −3 −2 0 17 18 19 31 32
CTRL 3 3 3 3 6*
EAE1 3 3 6*
EAE2 3 3 6*
EAE3 3 3 3 3 6*
Schematic representation of the study setup. The numbers show the number of
animals from each group scanned at that day. The day is relative to EAE induction,
baseline scans were done before induction, while the midpoint and endpoint scans
were done after induction. *Marks that the animal was sacriﬁced for histology on
the same day as being scanned.
Fig. 1. Schematic illustration of brain tissue sections. Regions of the mouse brain
analyzed by densitometry.
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Fig. 2. MTR maps in which mean MTR values were calculated. Illustrated by an EAE mouse brain at EAE midpoint.
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During scanning, the mice were anesthetized by 1.5% isoﬂurane in
O2, and the body temperature and respiratory frequencyweremoni-
tored and kept constant at 37 ± 1.5 °C and 80 ± 20 respiratory
cycles/min, respectively. The geometry was identical for all scans:
30 × 128 × 128 matrix size, 2.56 × 2.56 × 0.7 cm3 FOV, giving
0.2 × 0.2 × 0.23 mm3 resolution. For theMTR acquisition, a FLASH se-
quencewas used,with (Ms) andwithout (M0) an offsetmagnetization
transfer saturation pulse (−2000 Hz off resonance, Gaussian shaped,
10.4μT strength, 6.65ms duration, number of pulses: 1, 457 Hz band-
width, 400 degree ﬂip angle), 4 averages, TE = 2.3ms, TR = 28.5ms
and ﬂip angle = 10°. A T2-weighted (T2w) RARE imagewas acquired
with 1 average, TE = 9ms, TR = 1500ms and a RARE factor of 16.
2.5. Preparation of brain tissue
Mice were euthanized by cardiac puncture in surgical anesthe-
sia with fentanyl/ﬂuanisone/midazolam; the brains were removed
and ﬁxated in 4% paraformaldehyde for at least 7 days, then par-
aﬃn embedded. Seven μm serial sections between areas 165 and
195 in the mouse brain atlas (http://www.hms.harvard.edu/
research/brain) were analyzed. Sections were histochemically stained
for myelin with Luxol fast blue (LFB). For immunohistochemistry,
the sections were dewaxed and rehydrated before antigen retriev-
al in citrate buffer (pH 6.2). Sections were immunostained for myelin
with anti-Proteolipid Protein antibody (PLP, Serotec, Oxford, UK),
Fig. 3. Progression of MTR values over time. Mean MTR values in EAE induced mice (solid) and control animals (dashed). Dots (Filled: EAE mice. Open: Control mice) rep-
resent single MTR measurements. Error bars: standard deviation of mean MTR.
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for activated macrophages and microglia with anti-Mac3 (BD Bio-
sciences, Franklin Lakes, NJ, US) and for T-lymphocytes with anti
CD3 (Sigma-Aldrich, St. Louis, MO, US). Sections were blocked with
peroxidase blocking solution (Dako, Glostrup, Denmark), and visu-
alized with EnVision 3.3 - diaminobenzidine (Dako, Glostrup,
Denmark). The tissue sections were counterstained with hema-
toxylin. For each antibody, omission of the primary antibody served
as negative control. Normal brain tissue from the healthy controls
served as positive controls. Total (ferrous and non-ferrous) iron was
detected using diaminobenzidine (DAB) enhanced Turnbulls stain-
ing, as described by Hametner et al. (2013).
2.6. Characterization of brain tissue
LFB sections were scored in a blinded manner by two observ-
ers, using light microscopy (Zeiss, Axio Imager A2, 40x, Oberkochen,
Germany). For quantiﬁcation of myelin loss, we used a semi-
quantitative scoring system: no (0), minimal (0. 5), < 33% (1), 33–
66% (2) and > 66% (3) demyelination. Immunopositivity and iron
content were quantiﬁed by digital densiometry. Several sections of
the corpus callosum, cerebral cortex and deep graymatter were pho-
tographed as indicated in Fig. 1, with identical exposure and
brightness settings at 40× magniﬁcation (Zeiss AxioImager 2 with
Table 2
Region-wise comparison of MTR between groups.
Region EAE vs Control Acute vs chronic
EAE Control p-Value Midpoint Endpoint p-Value
Corpus callosum 42.8 ± 2.8% 40.1 ± 2.3% .03 (0.03) 42.1 ± 3.5% 43.5 ± 1.5% .22 (1)
Deep gray matter 38.3 ± 2.1% 36.1 ± 2.4% .007 (0.028) 37.9 ± 2.7% 38.7 ± 1.2% .46 (1)
Olfactory bulb 38.3 ± 2.0% 36.1 ± 3.7% .008 (0.028) 38.1 ± 2.5% 38.5 ± 1.6% .69 (1)
Cerebellum 37.3 ± 1.7% 35.2 ± 2.7% .01 (0.028) 37.3 ± 2.2% 37.2 ± 1.2% .96 (1)
Cerebral cortex 38.1 ± 2.2% 34.9 ± 2.5% .0004 (0.0015) 37.7 ± 2.9% 38.4 ± 1.1% .44 (1)
ANOVA of MTR value, with ﬁrst all EAE mice (from midpoint and endpoint) compared to their controls, then for the acute (midpoint) EAE group compared to the chronic
(endpoint) EAE group. Mean values are presented with ± a standard deviation. p-Values from the ANOVA is presented, with Holm-corrected p-value in parenthesis.
Fig. 4. Images of sections from corpus callosum (CC), deep gray matter (DG) and cerebral cortex (CX) immunostained for PLP, in controls, at peak EAE severity (EAE peak)
and at EAE endpoint (EAE chronic). All images at 40×.
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Zeiss AxioCam ERc 5s camera and Zeiss Zen 2012 ver 1.1.1 imaging
software), and shadow-corrected. Using Image processing and anal-
ysis in Java (ImageJ ver. 1.48f, U. S. National Institutes of Health;
Bethesda 2009), each grayscale image was manually thresholded
by an experienced physician (SW) in order to avoid quantitative reg-
istration of low-intensity background staining. Hematoxylin staining
was digitally removed by color deconvolution in ImageJ. The area
of immunopositivity in each image was then calculated, and ex-
pressed as the percentage of pixels, or relative area, in each image
with intensity within the threshold values. Finally, the regionmyelin
content was calculated by averaging values for all images within
the region.
2.7. MRI analysis
Images were analyzed using an in-house software written in
Matlab (R2012a; The Mathworks, Natick, MA). Magnetization trans-
fer ratio (MTR) was calculated using the formula: MTR = 100 × (M0–
Ms) / M0. A semi-automatic method was used to segment the brains
into anatomical regions. An anatomical segmentation map consist-
ing of 5 brain regions (corpus callosum, deep gray matter, olfactory
bulb, cerebellum and cerebral cortex) was drawn on the basis of the
baseline T2w image (Fig. 2). This mapwas superimposed on all other
subjects by linearly co-registering the T2w images using the Sta-
tistical ParametricMapping 8 package (SPM8;Wellcome Trust Center
for Neuroimaging, Oxford, England; http://www.ﬁl.ion.ucl.ac.uk/spm).
The mean MTR value was calculated in each region.
2.8. Statistical analysis
Statistical analyses were done using R (RCore2012). Analysis of
variance (ANOVA) was used to compare group differences. Com-
parison was done separately for the different brain regions, ﬁrst
comparing the EAE mice from midpoint and endpoint to the cor-
responding control mice (for MTR and weight, this was the control
mice scanned/weighed at the same time point; for histological
Table 3
Region-wise mean PLP area (myelin content).
Region EAE vs control
EAE Control p-Value
Corpus callosum 80.4 ± 7.0% 83.3 ± 5.1% .38(1)
Deep gray matter 48.7 ± 10.5% 48.3 ± 9.9% .93(1)
Cerebral cortex 10.7 ± 3.4% 9.7 ± 1.4% .53(1)
ANOVA of myelin content calculated as % of area stained with PLP in 4 locations in
each of the three regions. Data presented only for the pooled data from the EAE mice
compared to control mice. Mean values are presented with ± a standard deviation.
p-Values from the ANOVA is presented, with Holm-corrected p-value in parenthesis.
Fig. 5. % PLP area (myelin content). The mean myelin content from four different
locations in corpus callosum, deep gray matter and cerebral cortex for the control
mice, EAE mice at the midpoint and EAE mice at the endpoint. Error bars: stan-
dard deviation of PLP area.
Fig. 6. Myelin content correlation to MTR values. Linear regression of myelin content,
calculated from PLP stained brain tissue sections, and MTR values. Dots (Filled: EAE
mice. Open: Control mice).
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analysis, it was the tissue from the control mice from the end-
point); if a signiﬁcant difference was seen, a secondary orthogonal
comparison was done between the EAE mice from midpoint com-
pared to EAE mice from endpoint. For the quantitative data (MTR,
weight and PLP), the data were ﬁtted with a linear model. For the
LFB scoring, a generalized linear model was used. p-Values were
Holm-adjusted to account for multiple comparisons. The MTR value
was correlated to weight, EAE score and myelin content using linear
regression. In addition, to compensate for variation in MTR value
over time, a separate analysis was done using normalized MTR
values. Normalization was done segment-wise and time point wise,
by subtracting the meanMTR value of control animals. A p < .05 was
considered signiﬁcant.
3. Results
3.1. Region wise MTR values
Mean MTR values were signiﬁcantly higher in EAE mice than in
control mice in all regions after EAE induction, but no signiﬁcant
difference was seen between EAEmice at midpoint compared to the
endpoint (Table 2 and Fig. 3). At baseline, EAE mice had non-
signiﬁcantly higher than control mice (corpus callosum: ΔMTR = 0.1%,
p = .90; deep gray matter: ΔMTR = 0.7%, p = .49; olfactory bulb:
ΔMTR = 1.3%, p = .30; cerebellum: ΔMTR = 1.2%, p = .39; cerebral cortex:
ΔMTR = 0.9%, p = .38).
3.2. Myelin content
Myelin content assessed by immunohistochemical staining for
PLP (Fig. 4) was not signiﬁcantly different between the control mice
and EAE mice in any of the regions (Table 3 and Fig. 5). PLP area did
not correlate to MTR in any of the three areas assessed (corpus cal-
losum: R2 = .01, p = .63; deep gray matter: R2 = .08, p = .2; cerebral
cortex: R2 < .01, p = .97) (Fig. 6)
Myelin content scored by immunohistochemical staining for LFB
(Fig. 7) was not signiﬁcantly different between the control mice and
EAE mice in any of the regions (corpus callosum: p = .29; deep gray
matter: p = .29; cerebral cortex: p = .29) (Fig. 8).
3.3. Lymphocyte inﬁltration and iron accumulation
No inﬁltration of CD3 immunopositive lymphocytes was ob-
served in the examined brain tissue regions. Iron deposition could
not be detected in brain tissue from neither EAE nor control mice
(Fig. 9). Thus, no differences in iron content were detected between
the EAE mice and control mice in deep gray matter, corpus callo-
sum or cerebral cortex.
Fig. 7. Images of sections from corpus callosum (CC), deep gray matter (DG) and cerebral cortex (CX) immunostained for LFB, in controls, at peak EAE severity (EAE peak)
and at EAE endpoint (EAE chronic). All images at 40×.
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3.4. Weight and clinical scoring
Control mice was signiﬁcantly heavier than EAE mice, while the
chronic EAE mice at endpoint was heavier than the acute EAE mice
at midpoint (Table 4 and Fig. 10A). No correlation between MTR
values and weight was found (R2 < .01 for all regions) (Fig. 11). The
clinical score showed that EAE induced mice had increasing disease
severity from p.i. day 10 to 17, followed by an incomplete remis-
sion (Fig. 10B). No correlations betweenMTR values and cumulative
clinical scores were found (corpus callosum: R2 = .03, p = .42; deep
gray matter: R2 = .02, p = .53; olfactory bulb: R2 = .01, p = .60; cere-
bellum: R2 < .01, p = .99; cerebral cortex: R2 = .01, p = .63) (Fig. 12).
Analyses of non-cumulative clinical scores and normalized cumu-
lative clinical scores did not change the results.
All analyses were, in addition, done using normalizedMTR values,
giving similar results (data not shown).
4. Discussion
We have shown an unexpected increase in MTR value in the
brains of mice with MOG-EAE as compared to controls that do not
correlate to histopathological changes. MTR is considered to be a
semi-quantitative measure of myelin content, and a decrease inMTR
has previously been reported in a few other EAE studies (Aharoni
et al., 2013; Gareau et al., 2000; Rausch et al., 2003; Serres et al.,
2009). These studies, however, did not correlate MTR values to quan-
titative immunohistochemical measures.
In line with a previous study (Mackenzie-Graham et al., 2011),
we expected diffuse neurodegeneration and demyelination in the
brain of the EAE mice, and was interested in whether this could be
detected by a corresponding decrease in MTR values. There was,
however, no evidence for diffuse demyelination in our study, and
contrary to our expectations, the MTR value increased in EAE mice.
A difference in myelin content can probably not explain the in-
crease in MTR value in EAE mice compared to the controls. This
suggests that other methodological or pathophysiological mecha-
nisms affect the MTR values.
The segmentation of the MR images was done using linear co-
registration. Dehydration could change the morphology in the EAE
mouse brains, requiring a non-linear approach. We did not notice
any such problems in this study, and small misregistration would
not signiﬁcantly change the results since large 3D segments were
used. In our data, we observed a variation in the MTR values in the
control mice over time, which we would not expect from a phys-
iological point of view. In a previous study (Fjær et al., 2013), we
experienced a non-biological variation of the MTR value of control
animals over the span of eight weeks in the range 2%−5%. From this
experience, we expected to see some variation over a span of four
weeks, but we have stable MTR values over a span of 2–3 days. A
weakness in our study design is that we had to scan the mice over
several days. In particular, we scanned all the control mice the same
day. It is possible that the group differences seen in this study is
due to an error in the MTR value which is actually dependent on
the day the mice were scanned. To the best of our knowledge, the
relevant external factors were controlled for the following: M0 and
MT were always acquired with the same settings on the scanner,
without recalibrations between the two acquisitions; the receiver
gain was kept constant in all MTR acquisitions at all times; the tem-
perature of the animals, and the room, was held relatively constant;
images were reconstructed from raw data to control for changes that
could occur in on-scanner conversion.
MTR has been reported as a sensitive and speciﬁc indicator for
myelin content. As no signiﬁcant difference in myelin content was
found between EAE mice and control mice, we might not expect a
clear correlation between MTR and myelin content, as we have pre-
viously demonstrated in the cuprizone model (Fjær et al., 2013). The
lack of a signiﬁcant demyelination may also explain why we did not
see the same correlations as in previous studies of EAE model in
marmosets (Blezer et al., 2007) and guinea pigs (Cook et al., 2004;
Gareau et al., 2000).
Iron has been shown to affect the magnetization transfer effect
in the brain (Smith et al., 2009), and has been exploited in MTR
Fig. 8. LFB score (myelin content). Box plot of distribution of LFB scores in corpus
callosum, deep gray matter and cerebral cortex for control mice and EAE mice. The
box plot represents minimum value, lower quartile, median, upper quartile and
maximum value.
Table 4
Mean weight over time.
EAE vs control Acute vs chronic
EAE Control p-Value Midpoint Endpoint p-Value
21.3 ± 2.3g 23.0 ± 1.3g .02 20.2 ± 2.0g 22.8 ± 1.6g .001
ANOVA of weight, with ﬁrst all EAE mice (from midpoint and endpoint) compared
to their controls, then for the acute (midpoint) EAE group compared to the chronic
(endpoint) EAE group. Mean values are presented with ± a standard deviation.
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imaging of rectal cancer to detect ﬁbrosis (Martens et al., 2014;
Papanikolaou et al., 2000). It has been suggested that iron is an im-
portant indicator of different physiological and pathological processes
in MS (Bagnato et al., 2013), and we therefore investigated whether
iron could have inﬂuenced out MTR changes. We could, however,
not detect any differences in iron content between EAE inducedmice
and control mice by Turnbull’s DAB-enhanced iron staining, making
it unlikely that iron inﬂuenced our MTR ﬁndings. This is sup-
ported by a recent study reporting no evidence of iron accumulation,
other than in single iron-containing perivascular or meningeal mac-
rophages in individual lesions inMOG induced EAEmice (Schuh et al.,
2014). In our study, we did not ﬁnd any Mac-3 immunopositive ac-
tivated microglia or macrophages in the brain tissue sections. In
MOG1-125 induced EAE, the degree of inﬂammation and demy-
elination in the brain is variable compared to the more typical
affection of the spinal cord. If present in the brain, lesions occurmore
frequently in the caudal aspects and in the cerebellum than in the
frontal parts. As such, we do not ﬁnd that the absence of lympho-
cyte inﬁltration and microglial activation is atypical in our
experiment. Dehydration is another factor that can inﬂuence MTR
values, as the pools of water affected by magnetization transfer may
change relatively in size. This effect was recently exploited in a study
employingmagnetization transfer to show changes in hydration state
in the achilles tendons (Syha et al., 2014). MTR has shown a stron-
ger, inverse correlation with total water content (r = − .65) than to
myelinwater content (r = − .36) (Vavasour et al., 2011). In EAEmodels,
dehydration has been shown primarily in the spinal cord, but smaller
degrees of dehydration has also been seen in the brain, with sicker
animals having higher degree of dehydration (Orr et al., 1994). We
used weight measures as a surrogate indicator of dehydration, but
did not detect any correlation between weight and MTR values, in-
dicating that a hydration effect probably did not inﬂuence MTR
Fig. 9. Representative images of sections from positive controls, and from corpus callosum in control mice (EAE control), at peak EAE severity (EAE peak), and at EAE end-
point (EAE chronic). Upper row: Immunostained for CD3 positive T-lymphocytes. Positive control: Tonsil. Mid row: Turnbulls DAB-enhanced iron stain. Positive control:
Spleen. Lower row: Immunostained for activated microglia and macrophages (Mac3). Positive control: cuprizone-exposed mouse brain. There were no signs of lymphocyte
inﬁltration, iron deposition or microglia activation in any of the investigated regions at neither time point. All images at 40×.
Fig. 10. Weight and disease score over time in EAE induced mice. Line represents
group mean weight/clinical score. Error bars: Standard deviation of weight/clinical
score. A: Body weight in grams. B: Clinical disease score.
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Fig. 11. Correlation between weight and MTR value. Dots (Filled: EAE mice. Open: Control mice).
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Fig. 12. Correlation between cumulative clinical scores and MTR values. Dots represent EAE mice scanned at the midpoint and the endpoint.
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changes observed in our study. A study of hypo- and isointense T1
lesions inMS brains suggests that a lowerMTR in hypointense lesions
is not due to lowermyelin content, but to axonal loss (Vavasour et al.,
2007), which is supported by a study onMS lesions showing a higher
correlation betweenMTR and axonal density than to myelin content
(van Waesberghe et al., 1999). Axonal density was not examined
in our study, but was not expected to be higher in the EAE induced
mice compared to control mice. It was therefore unlikely that axonal
density inﬂuenced our MTR ﬁndings.
If MTR change would be sensitive to diffusely damaged brain
matter, we would expect to see a correlation between the severity
of disease in the EAE mice and MTR values. No such correlation was
observed in our study, implying that MTR of the brain done in this
study had no predictive value for the severity of the disease. To our
knowledge, a correlation between MTR and clinical disease score
in the EAE mouse model has not been reported in other studies
either. The spinal cord is important in the pathology of the EAEmice.
We did not do spinal cord MTR, and can thus not say anything about
the sensitivity of spinal cord MTR on myelin content. Acquisition
parameters for MTR on preclinical MRI scanners have not been stan-
dardized. Both spin-echo and ﬂash sequences are being used, with
a range of repetition times, echo times and ﬂip angles. A Gaussian
shaped off-resonance pulse is most common, but the offset fre-
quency varies from 1000Hz (Rausch et al., 2009) to 5000Hz (Boretius
et al., 2012), and it is typically not noted explicitly whether the offset
is positive, negative or both. The strength, saturation time, ﬂip angle,
bandwidth and number of saturation pulses are also variable, and
often not reported in research papers. The acquisition parameters
used in this study is similar to that of other MTR studies done on
7 Tesla preclinical scanners (Boss et al., 2008; Fjær et al., 2013; Rausch
et al., 2009), with the possible exception that this study used a neg-
ative offset frequency (this is not explicitly denoted in the other
studies). The negative offset should theoretically make a qualita-
tively difference, as it is the broader eigenfrequency spectrum of the
macromolecules that causes the MT effect, rather than a chemical
shift. Thus, we did not expect that the acquisition parameters used
in this study would be the cause of the observed increase in MTR
values in EAE mice.
EAE can be induced in several different ways, giving different
disease progress and pathology (Kuerten et al., 2007). To our knowl-
edge, only one previous MTR study on MOG induced EAE in mice
has been reported (Aharoni et al., 2013). This study did not show
the same disease progress in the EAE mice as observed in our study.
Whereas they reached a plateau in disease severity 17 days after
EAE induction, we saw a remission of the disease 17 days after EAE
induction, also followed by an increase in weight andmyelin content.
They found that the EAE induced mice had signiﬁcant lower mean
MTR value than a control group in several regions from 13 days to
27 days after induction, but no correlation tests betweenMTR values
andmyelin content from immunohistopathology examinations were
reported. Their MTRmeasurements were done using a 9.4 Tesla pre-
clinical MRI scanner, using a spin-echo sequence.
In our study, we have seen that MTR values increase in MOG1-
125 EAE mice compared to control mice, and that MTR does not
correlate to myelin content or disease severity score. We have ex-
plored possible causes for our ﬁndings, showing that weight/
dehydration and iron deposits probably did not affect the results.
A possible variation in MTR value from day to day may have caused
false signiﬁcant results. The EAE induced mice showed a typical
disease course, shown in previous studies, and the MTR acquisi-
tion parameters was similar to those used in other preclinical MTR
studies, but we did not see signiﬁcant changes in myelin content
in histopathology. Our ﬁndings indicate that MTR measures of the
brain can give signiﬁcant differences between control mice and EAE
mice not caused by known pathology, and may not be useful sur-
rogate markers for demyelination in the MOG1-125 mouse model.
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